Adipocyte-secreted inflammatory factors (Adipokines)

Adipocyte-secreted inflammatory factors, commonly referred to as adipokines, are a diverse group of bioactive proteins—including Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-alpha), and Leptin—secreted by adipose tissue that mediate systemic inflammation and metabolic homeostasis (NCBI, PMC3602985). In the context of malignancy, these factors significantly influence cancer-associated gene expression by activating key oncogenic pathways such as JAK/STAT3, PI3K/Akt, and MAPK within the tumor microenvironment (PubMed, 30113460; Nature Reviews Cancer, 2020). This signaling promotes tumor cell proliferation, survival, chemoresistance, and epithelial-mesenchymal transition (EMT), facilitating metastasis (Frontiers in Endocrinology, 2021). While the collective secretome is not a single therapeutic target, individual components like IL-6 and TNF-alpha are well-established targets for monoclonal antibodies such as Tocilizumab and Infliximab, which are used to treat inflammatory conditions and are under investigation for their role in mitigating obesity-driven cancer progression (NIH, Obesity Fact Sheet; PubMed, 32824000). Therapeutic challenges include the pleiotropic nature of these cytokines, where systemic inhibition can lead to significant immunosuppression and metabolic side effects (StatPearls, Cytokine Inhibitors). Targeting the interaction between these adipokines and their respective receptors remains a key area of research for developing precision oncology treatments in patients with obesity-related cancers (Journal of Clinical Investigation, 2013).

Other names

AdipokinesAdipocytokinesAdipose-derived inflammatory mediatorsAdipose secretomeObesity-associated inflammatory factors

The mechanism of action involves the pharmacological inhibition of specific pro-inflammatory cytokines (e.g., IL-6, TNF-alpha) or their respective receptors to disrupt downstream oncogenic signaling pathways, such as JAK/STAT3, NF-kB, and PI3K/Akt, which drive cancer progression and chronic inflammation (PubMed, 32824000; Nature Reviews Cancer, 2020).